Formosa Laboratories, Inc. (TPE:4746)
Taiwan · Delayed Price · Currency is TWD 52.30
+0.10 (0.19%)
Jun 18, 2026, 1:30 PM CST
Formosa Laboratories Market Cap
Formosa Laboratories has a market cap or net worth of 6.29 billion as of June 18, 2026. Its market cap has decreased by -25.07% in one year.
Market Cap
6.29B
Enterprise Value
8.42B
Revenue
4.77B
Ranking
n/a
PE Ratio
18.74
Stock Price
52.30
Market Cap Chart
Since March 2, 2011, Formosa Laboratories's market cap has increased from 5.60B to 6.29B, an increase of 12.32%. That is a compound annual growth rate of 0.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 6.29B | -11.80% |
| Dec 31, 2025 | 7.13B | -13.81% |
| Dec 31, 2024 | 8.27B | -32.55% |
| Dec 29, 2023 | 12.27B | 38.78% |
| Dec 30, 2022 | 8.84B | 21.49% |
| Dec 30, 2021 | 7.28B | 43.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Foresee Pharmaceuticals | 12.45B |
| Handa Pharmaceuticals | 11.86B |
| Standard Chemical & Pharmaceutical | 11.19B |
| Alar Pharmaceuticals | 7.68B |
| Orient Pharma | 5.62B |
| LIWANLI Innovation | 5.46B |
| SCI Pharmtech | 5.03B |
| Orient EuroPharma | 3.94B |